WaferGen, Luxembourg Biobank Partner on Molecular Signatures | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen BioSystems today said that it will collaborate with the Integrated BioBank of Luxembourg to co-develop molecular signatures for diagnostic research and commercial applications.

Fremont, Calif.-based WaferGen said that IBBL will purchase a SmartChip Real-Time PCR system and use it to discover and validate gene expression patterns. It added that the partners plan to file for approval in Europe of the molecular signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.